HRT Financial’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-19,923
Closed -$263K – 5125
2026
Q1
$327K Buy
+19,923
New +$489K ﹤0.01% 2808
2023
Q1
– Sell
-3,571
Closed -$305K – 3062
2022
Q4
$305K Buy
+3,571
New +$302K ﹤0.01% 1713
2022
Q3
– Sell
-11,136
Closed -$1.08M – 3353
2022
Q2
$1.08M Buy
+11,136
New +$1.14M 0.01% 861
2022
Q1
– Sell
-5,414
Closed -$730K – 3713
2021
Q4
$730K Buy
+5,414
New +$754K ﹤0.01% 1468
2021
Q3
– Sell
-55,004
Closed -$7.39M – 3669
2021
Q2
$7.05M Buy
+55,004
New +$6.47M 0.06% 235
2021
Q1
– Sell
-1,180
Closed -$211K – 3066
2020
Q4
$211K Sell
1,180
-5,372
-82% -$1.19M ﹤0.01% 1477
2020
Q3
$1.44M Buy
+6,552
New +$1.46M 0.04% 360

Other funds holding QDEL

HRT Financial's QDEL Position: Q2 2026 in Review

HRT Financial sold out of QuidelOrtho (QDEL) in Q2 2026, closing a stake of 19,923 shares — an estimated $263K sold.

HRT Financial first reported a position in QDEL in Q3 2020 and held it in 7 quarters. The position peaked at $7.05M in Q2 2021. 245 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • HRT Financial reported no remaining QuidelOrtho position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 19,923 QuidelOrtho shares in Q2 2026, an estimated $263K.
  • HRT Financial first reported a position in QuidelOrtho in Q3 2020 and held it in 7 quarters.
  • HRT Financial's QuidelOrtho position peaked at $7.05M in Q2 2021.
  • 245 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.